Aug 24, 2021 / 08:00PM GMT
Keith Frances Bachman - BMO Capital Markets Equity Research - MD & Senior Research Analyst
Okay. Good afternoon, everybody. It's Keith Bachman here again from BMO. This is our last event of the day, at least for me, I'm not sure about my colleagues on the tech conference, but we're happy to have Ceridian here. I will just, as usual, launch into questions. (Operator Instructions)
And maybe, David, I'll go ahead and start it from my end. Thank you very much at the outset for joining us today. We're happy to have Ceridian present to BMO. And hopefully, you've had a good set of meetings during the day. Unfortunately, I haven't been able to join those meetings because I've been back-to-back fireside, so to speak.
But maybe you can talk about -- this is the question I've been starting out with many of the software companies today is, if you think about Ceridian's opportunity within the broader HCM landscape, what are you most excited about? What do you think is most intriguing from a growth perspective in terms of driving incremental dollars of growth if you look out over the next 12 to 18
Ceridian HCM Holding Inc at BMO Virtual Technology Summit Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot